(Press-News.org) CHICAGO — Today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will unveil a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and more accurately than the current standard — and that could translate to vastly improved patient outcomes. A second study highlights how certain generative AI tools can empower adolescents by helping them to gather useful medical information.
Together, these findings spotlight the potential of AI to make a profound, positive difference in people’s lives when thoughtfully integrated into clinical laboratory medicine.
Lyme test offers hope for early, effective treatment
Each year, more than 475,000 Americans are diagnosed with Lyme disease — a number that is only expected to climb due to climate change expanding the range of areas where ticks can live. When caught early, the condition responds well to antibiotics. However, the typical test — called two-tier serology — detects early Lyme accurately only 30% of the time. It’s a significant missed opportunity, since more than half of Lyme patients not diagnosed or treated within the first few weeks of infection will develop long-term health problems such as fatigue, neurocognitive issues, and arthritis.
The new test leverages AI to offer major improvement. Its sensitivity and specificity are both over 90%, “meaning 9 out of 10 patients are going to get a correct diagnosis and receive appropriate treatment, which lowers the risk of chronic illness significantly,” said Holly Ahern, a microbiologist and chief scientific officer at ACES Diagnostics.
Ahern and team built on research in rhesus macaque monkeys, whose immune response to the bacteria causing Lyme is similar to humans, to develop a panel that looks for 10 proteins (antigens) and is completed as a single test. This approach is an improvement over the two-tier method, which may require up to four tests.
Next, they analyzed blood samples from humans, including 123 people with Lyme disease and 197 uninfected individuals, to test whether adding machine learning to the test could bolster performance by detecting unique immune patterns. “You and I might get infected by the same bacteria, but we might both produce different antibody responses to it,” said Ahern. “With these antigens matched with a decision-tree–based classifier, we can actually pick that up in each individual case.”
The team found an algorithm that improved accuracy across all disease stages, correctly flagging infection in over 90% of early cases (versus 27% with the standard method). They hope the test — which, according to Ahern, is relatively inexpensive and works on standard laboratory equipment — will be commercially available by the end of 2026.
Medicine-GPT as an informational tool for adolescents
A second study assessed Medicine-GPT, a doctor-developed, free-to-use ChatGPT custom model. The research focused on adolescents because they tend to be early tech adopters who frequently search for information online, often on topics they don’t feel comfortable discussing with adults.
“Medicine-GPT shows promise as a powerful tool for addressing adolescent health inquiries, outperforming ChatGPT-4 in completeness, reasoning, and overall medical helpfulness,” said Austin Jin, a high school research intern at Weill Cornell Medicine in New York.
Jin and team gathered over 100 clinical questions related to lab medicine and diagnostics from Reddit’s “Ask Doctors” forum, filtering for posts by people aged 10-19 and sorted by “top” interactions. They evaluated how well the customized chatbot provided useful answers compared to its predecessor, ChatGPT-4.
Both models demonstrated complete factual accuracy, but Medicine-GPT outperformed ChatGPT-4 on other measures, achieving ratings of 66.6% for completeness, 60% for reasoning, and 46.6% for helpfulness (compared to 20%, 33.3%, and 23.3%, respectively, for ChatGPT-4). Both models received high ratings on clarity (80% for Medicine-GPT vs. 70% for ChatGPT-4).
However, a common challenge is that these tools can leave teenagers feeling overwhelmed, especially when chatbots present rare, fatal conditions as diagnostic possibilities. “This highlights the need for future AI tools to not only be medically accurate, but also context-aware, user-sensitive, and aligned with how clinicians communicate,” Jin said.“Rather than discouraging use, providers can guide adolescents on how to use these tools responsibly, emphasizing that AI … should never replace professional medical advice or personalized evaluation.”
About ADLM 2025
ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) offers 5 days packed with opportunities to learn about exciting science from July 27-31 in Chicago. Plenary sessions will explore urgent problems related to clinical artificial intelligence (AI) integration, fake medical news, and the pervasiveness of plastics, as well as tapping into the promise of genomics and microbiome medicine for personalized healthcare.
At the ADLM 2025 Clinical Lab Expo, more than 800 exhibitors will fill the show floor of the McCormick Place Convention Center in Chicago, with displays of the latest diagnostic technology, including but not limited to AI, point-of-care, and automation.
About the Association for Diagnostics & Laboratory Medicine (ADLM)
Dedicated to achieving better health for all through laboratory medicine, ADLM (formerly AACC) unites more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from 110 countries around the world. Our community is at the forefront of laboratory medicine’s diverse subdisciplines, including clinical chemistry, molecular diagnostics, mass spectrometry, clinical microbiology, and data science, and is comprised of individuals holding the spectrum of lab-related professional degrees, certifications, and credentials. Since 1948, ADLM has championed the advancement of laboratory medicine by fostering scientific collaboration, knowledge sharing, and the development of innovative solutions that enhance health outcomes. For more information, visit www.myadlm.org.
END
Breaking research at ADLM 2025: AI poised to revolutionize Lyme disease testing, treatment
Together, these findings spotlight the potential of AI to make a profound, positive difference in people’s lives when thoughtfully integrated into clinical laboratory medicine
2025-07-28
ELSE PRESS RELEASES FROM THIS DATE:
CD4+ T cell-mediated immune drift in biologic treatment of inflammatory skin diseases
2025-07-28
Immune-inflammatory skin diseases (e.g., psoriasis, atopic dermatitis) involve dysregulation of CD4+ T-cell subsets (Th1/Th2/Th17/Treg) and cytokine networks (IL-17/IL-23/IL-4). Biologics targeting specific pathways—TNF-α, IL-17, IL-12/23, IL-4/13, PD-1/PD-L1—revolutionize treatment but trigger immune drift, shifting CD4+ T-cell polarization and causing adverse skin reactions. This review synthesizes mechanisms, clinical manifestations, and management strategies.
Mechanisms of Immune Drift by Biologic Class
(Summarized in Table 1)
1. TNF-α Inhibitors (Etanercept, Infliximab, Adalimumab)
Mechanism: Blocking ...
Spotlight on technology to protect older Australians from respiratory infections
2025-07-28
Simple technology that harnesses ultraviolet light to ‘zap’ airborne viruses has been shown to significantly lower the number of respiratory infections in aged care facilities, paving the way for smarter infection control.
Adapted by scientists from Flinders Health and Medical Research Institute (FHMRI) and SAHMRI, the technology is based on using germicidal ultraviolet (GUV) appliances which purify the air with UV-C light rays and deactivate harmful micro-organisms like viruses and bacteria.
The new study published in JAMA Internal Medicine trialled commercially-available GUV appliances in aged care facilities ...
There’s something in the air
2025-07-28
Researchers at the University of Tokyo explored how female body odor can influence behaviors in men. They found certain scent compounds in female body odor increased during ovulation and can subtly influence how men feel. When these scents were added to armpit odor samples, men rated them as more pleasant and faces associated with the samples as more attractive. The scents also seemed to reduce stress. The team states this is not evidence of pheromones in humans, but that smell might subtly shape how we people interact.
While they’re a common staple of pop culture, especially in romantic comedies, pheromones, behavior-altering ...
New insights could help phages defeat antibiotic resistant bacteria
2025-07-28
UNDER EMBARGO UNTIL 16:00 UK TIME (11:00 AM ET) ON MONDAY 28 JULY 2025
New insights could help phages defeat antibiotic resistant bacteria
Researchers at the University of Southampton have worked out how bacteria defend themselves against viruses called phages and the new insights could be key to tackling antibiotic resistance.
Phages are seen as a promising alternative treatment to antibiotics. Unpicking how bacteria protect themselves, and how phages might overcome these defences, could be a significant step in defeating antibiotic resistant bacteria.
Phages, ...
New system dramatically speeds the search for polymer materials
2025-07-28
Cambridge, MA – Scientists often seek new materials derived from polymers. Rather than starting a polymer search from scratch, they save time and money by blending existing polymers to achieve desired properties.
But identifying the best blend is a thorny problem. Not only is there a practically limitless number of potential combinations, but polymers interact in complex ways, so the properties of a new blend are challenging to predict.
To accelerate the discovery of new materials, MIT researchers ...
Safety of JN.1-updated mRNA COVID-19 vaccines
2025-07-28
About The Study: In this nationwide cohort study, no increased risk of 29 adverse events was observed after vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage in approximately 1 million adults.
Corresponding Author: To contact the corresponding author, Niklas Worm Andersson, MD, PhD, email nian@ssi.dk.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.23557)
Editor’s Note: Please see the article for additional information, ...
Type 2 diabetes and financial outcomes
2025-07-28
About The Study: The findings of this study suggest that patients with type 2 diabetes may experience substantially more adverse financial outcomes compared with patients without diabetes, highlighting the need to consider patient financial health when treating type 2 diabetes, particularly for patient groups at higher risk.
Corresponding Author: To contact the corresponding author, Cazilia Loibl, PhD, CFP, email loibl.3@osu.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.23453)
Editor’s ...
A financial toll on patients with type 2 diabetes
2025-07-28
Embargoed until 11 a.m. ET, July 28, 2025
In a first-of-its-kind study, researchers used a unique dataset to show that patients with type 2 diabetes have significantly worse financial outcomes than other patients.
Findings showed diabetes patients fared worse on all seven financial outcomes studied, including below-prime credit scores, medical and non-medical debt in collections, 60-plus-day delinquent debt, debt charge-offs, bankruptcy filings and foreclosure.
The diabetes patients in this study were compared to people who had a blood test ...
Safflower yellow pigments in coronary heart disease: Mechanisms, applications, and future perspectives
2025-07-28
Coronary heart disease (CHD), characterized by atherosclerosis-induced myocardial ischemia, remains a leading cause of mortality in China. Safflower yellow pigments (SYPs), the primary bioactive components of Carthamus tinctorius L., consist mainly of quinochalcone C-glycosides, with hydroxysafflor yellow A (HSYA) and anhydrosafflor yellow B (AHSYB) as key constituents. This review synthesizes evidence on SYPs' mechanisms, therapeutic applications, and future directions in CHD management.
Chemical Composition and Pharmacokinetics
SYPs comprise over 20 identified compounds, including HSYA and AHSYB, which confer cardiovascular protection, anti-inflammatory, and antioxidant activities. ...
TraMA: new RNA-based measure predicts mortality risk and tracks aging
2025-07-28
“TraMA is likely to be of particular value to researchers interested in understanding the biological processes underlying health and aging, and for social, psychological, epidemiological, and demographic studies of health and aging.”
BUFFALO, NY — July 28, 2025 — A new research paper was published in Aging (Aging-US) Volume 17, Issue 6, on June 13, 2025, titled “Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA).”
In ...
LAST 30 PRESS RELEASES:
New Canadian study reveals where HIV hides in different parts of the body
Lidocaine poisonings rise despite overall drop in local anesthetic toxicity
Politics follow you on the road
Scientists blaze new path to fighting viral diseases
The mouse eye as a window to spotting systemic disease
AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs
FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials
Exploring the therapeutic potential of cannabidiol for Alzheimer's
We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say
Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results
Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity
Seeing double: Clever images open doors for brain research
Inhaler-related greenhouse gas emissions in the US
UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions
A surgical handover system for patient physiology and safety
Cardiovascular health changes in young adults and risk of later-life cardiovascular disease
Nurse workload and missed nursing care in neonatal intensive care units
How to solve the remote work stalemate – dissertation offers tools for successful hybrid work
Chip-based phonon splitter brings hybrid quantum networks closer to reality
Texas Children’s researchers create groundbreaking tool to improve accuracy of genetic testing
Milken Institute, Ann Theodore Foundation announce more than $2.5 million in new funding for sarcoidosis research and launch new call for proposals
Boston University professor to receive 2025 Eugene Braunwald Academic Mentorship Award
Pusan National University researchers reveal how forest soil properties influence arsenic mobility and toxicity in soil organisms
Korea University researchers find sweet taste cells resist nerve damage through c-Kit protein
HealthFORCE, AAPA, and West Health release “Aging Well with AI” – first in a two part series on AI and the healthcare workforce
The real reasons Endurance sank — study finds Shackleton knew of ship’s shortcomings
Marine heatwaves have hidden impacts on ocean food webs and carbon cycling
Order from disordered proteins
Rocket test proves bacteria survive space launch and re-entry unharmed
New wheat diversity discovery could provide an urgently-needed solution to global food security
[Press-News.org] Breaking research at ADLM 2025: AI poised to revolutionize Lyme disease testing, treatmentTogether, these findings spotlight the potential of AI to make a profound, positive difference in people’s lives when thoughtfully integrated into clinical laboratory medicine